Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 8, 2011, Pages 2075-2080

  Zhang, Guoyou ^a   Li, Ming ^a   Jin, Jing ^a   Bai, Yushu ^a   Yang, Changwei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; Metastasis; MMP 9 expression; Osteosarcoma; S100a4

Indexed keywords

EID: 84863235771     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bjørnland K, Flatmark K, Pettersen S, et al (2005). Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res, 127, 151-6.
2. Berge G, Pettersen S, Grotterød I, et al (2010). Osteopontin-An important downstream effector of S100A4-mediated invasion and metastasis. Int J Cancer, 18, 240-6.
3. Bakhshi S, Radhakrishnan V (2010). Prognostic markers in osteosarcoma. Expert Rev Anticancer Ther, 10, 271-87.
4. Chen NH, Liu JW, Zhong JJ (2008). Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J Pharmacol Sci, 108, 212-6.
5. Cho HJ, Lee TS, Park JB, et al (2007).Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol, 40, 1069-76.
6. Ferrari C, Benassi S, Ponticelli F, et al (2004). Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years. Acta Orthop Scand, 75, 487-91.
7. Himelstein BP, Asada N, Carlton MR, et al (1998).Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma. Med Pediatr Oncol, 31, 471-4.
8. Huang LY, Xu Y, Cai GX, et al (2011). S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer. World J Gastroenterol, 17, 69-78.
9. Hoon DS, Ferris R, Tanaka R, et al (2011). Molecular mechanisms of metastasis. J Surg Oncol, 103, 508-17.
10. Ismail NI, Kaur G, Hashim H, et al (2008). S100A4 overexpression proves to be independent marker for breast cancer progression. Cancer Cell Int, 8, 12.
11. Kido A, Tsutsumi M, Iki K, et al (1999).Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats. Cancer Lett, 137, 209-16.
12. Kushlinsky NE, Solovyov YN, Babkina IV, et al (2010).Matrix metalloproteinases 2, 7, 9 and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors. Bull Exp Biol Med, 149, 233-5.
13. Lo JF, Yu CC, Chiou SH, et al (2011). The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res, 71, 1912-23.
14. Mencía N, Selga E, Rico I, et al (2010). Overexpression of S100A4 in human cancer cell lines resistant to methotrexate. BMC Cancer, 10, 250-6.
15. Ma X, Yang Y, Wang Y, et al (2010). Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. Cancer Lett, 299, 171-81.
16. Matsuyama Y, Takao S, Aikou T (2002). Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol, 80, 105-10.
17. Tarabykina S, Griffiths TR, Tulchinsky E, et al (2007). Metastasis-associated protein S100A4: spotlight on its role in cell migration. Curr Cancer Drug Targets, 7, 217-28.
18. Yang X, Staren ED, Howard JM, et al (2001). Invasiveness and MMP expression in pancreatic carcinoma. Surg Res, 98, 33-9.